Study finds program has improved health agencies' preparedness for bioterror and disease outbreaks

A federal program designed to help metropolitan public health agencies prepare to deliver essential medicines to the public after a large-scale bioterror attack or natural disease outbreak has succeeded in improving the level of readiness, according to a new RAND Corporation study. Researchers ...

Scientists uncover secrets of potential bioterror virus

GALVESTON, Texas Researchers at the University of Texas Medical Branch at Galveston have discovered a key tactic that the Rift Valley fever virus uses to disarm the defenses of infected cells. The mosquito-borne African virus causes fever in humans, inflicting liver damage, blindness and even ...

Germ-Fighting Inhaler Could Fend Off Bioterror Agents

Makers say it may protect first responders, or people with weak immune systems MONDAY, Dec. 3 (HealthDay News) -- Mention inhalers and most people think of asthma, but new research shows that inhalers could become infection-fighting, lifesaving gear for firemen, emergency workers and o...

New Strains of TB Can Be Used as a Powerful Bioterror Weapon

Despite billions of dollars spent on national security in airports, a man infected with XDR (extensively drug resistant) tuberculosis was allowed to travel unhindered into the United States, underscoring how drug-resistant strains of the disease could be used in a bioterrorist attack against the U...

Aethlon Medical Announces U.S. Army Agreement

... virulent Zaire strain of Ebola (ZEBOV). Hemorrhagic viruses are potential bioterror and pandemic threats, whose lethality prohibits the ability to conduct huma...nt outcomes and serves as a broad-spectrum treatment countermeasure against bioterror and pandemic threats. Additional information regarding Aethlon Medical can ...

DOR BioPharma Appoints Christopher P. Schnittker, CPA, as Vice President of Administration and Controller

...ize products based on its technology, including orBec(R), particularly in light of the significant uncertainty inherent in developing vaccines against bioterror threats, manufacturing and conducting preclinical and clinical trials of vaccines, and obtaining regulatory approvals, that its cash expenditures will...

Aethlon Medical Releases Shareholder Letter to Discuss the Treatment of Hepatitis-C Virus (HCV)

...ce markets. Pending the outbreak of a pandemic or bioterror threat, our primary focus in these markets will be...opurifier(R) as a treatment countermeasure against bioterror and pandemic threats. In this regard, we were rec...y and civilian populations from viruses considered bioterror and pandemic threats, we plan to provide BARDA our...

Aethlon Medical Discloses New HIV/AIDS Treatment Data

...irus (HIV), and serves as a broad-spectrum treatment countermeasure against bioterror and emerging pandemic threats. The Hemopurifier(R) also holds promise in c...ruses untreatable with drug therapy, including several of world's deadliest bioterror and pandemic threats. These include: Dengue hemorrhagic fever (DHF), Ebola...

Aethlon Medical Confirms Hemopurifier(R) Is a Treatment Candidate Against Swine Flu Virus

...fier(R) as a broad-spectrum countermeasure against bioterror and pandemic threats, including influenza, is avai... a broad-spectrum treatment countermeasure against bioterror and emerging pandemic threats. The Hemopurifier(R...ug therapy, including several of world's deadliest bioterror and pandemic threats. These include: Dengue hemor...

Aethlon Medical Announces Engagement of RedChip Companies to Initiate Investor and Media Relations Programs

...irus (HIV), and serves as a broad-spectrum treatment countermeasure against bioterror and emerging pandemic threats. The Hemopurifier(R) also holds promise in ca...ruses untreatable with drug therapy, including several of world's deadliest bioterror and pandemic threats. These include: Dengue hemorrhagic fever (DHF), Ebola ...

bioterror in Medical Technology

DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD

...ize products based on its technology, including orBec(R), particularly in light of the significant uncertainty inherent in developing vaccines against bioterror threats, manufacturing and conducting preclinical and clinical trials of vaccines, and obtaining regulatory approvals, that its cash expenditures will...

Aethlon Medical to Present at the 2009 RedChip Small-Cap Investor Conference on June 16, 2009

...irus (HIV), and serves as a broad-spectrum treatment countermeasure against bioterror and emerging pandemic threats. The Hemopurifier(R) also holds promise in c...ruses untreatable with drug therapy, including several of world's deadliest bioterror and pandemic threats. These include: Dengue hemorrhagic fever (DHF), Ebola...

Elusys' Anthrax Anti-Toxin, Anthim(TM), Enters Second Phase I Clinical Study

... can still fail to prevent death from the damaging effects of anthrax toxins. In addition, antibiotic resistant strains of anthrax could be used in a bioterror attack, making the medical need for anti-toxin therapy even more acute. Anthim Background Anthim is a high-affinity, humanized and deimmuniz...

DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation

...ize products based on its technology, including orBec(R), particularly in light of the significant uncertainty inherent in developing vaccines against bioterror threats, manufacturing and conducting preclinical and clinical trials of vaccines, and obtaining regulatory approvals, that its cash expenditures will...

Niaid / Barda Awards Elusys a $12 Million Contract to Further Develop Anthim, the Company's Anthrax Therapeutic

...the FDA and is being developed under the FDA Animal Rule, a regulatory process specifically designed for the development of medical countermeasures to bioterror threats. In April of 2007, Anthim was selected to R&D Directions' list of "100 Great Investigational Drugs. About Elusys' Heteropolymer Antibody(TM) ...

SIGA Passes First Hurdle with Lassa Fever Antiviral ST-193

...g as a significant deterrent and defense against the use of arenaviruses as bioterror weapons. Six separate arenaviruses are classified as Category A pathogens b...the CDC reports estimates of as many as 300,000 new cases each year), and a bioterror threat, due to its previous history as an object of weaponization research....

bioterror in Biological News

UCF professor develops vaccine to protect against black plague bioterror attack

A University of Central Florida researcher may have found a defense against the Black Plague, a disease that wiped out a third of Europe's population in the Middle Ages and which government agencies perceive as a terrorist threat today. UCF Professor Henry Daniell and his team have developed a...

Drug aimed at 2 bioterror agents blocks live viral infection, Weill Cornell team reports

NEW YORK (Dec. 19, 2007) -- Two deadly and highly infectious viruses -- both potential bioterror threats -- may have met their match in a new drug developed by scientists at Weill Cornell Medical College in New York City. Hendra and Nipah viruses are related, newly recognized zoonotic viruses t...

Secret of smallpox's success may lead to bioterror cure

In disease, as in war, offensive strategies can become weaknesses, if the defenders see the enemy coming and compensate for its weapons. By manipulating what is perhaps the most devastating trick in cellular weaponry of pox viruses like smallpox, Arizona State University virologist and Biodesign...

Study finds the air rich with bacteria

...elp explain temporal spikes, which is important in bioterror surveillance," adds Eoin Brodie, also with Berkele...ally potent bacterium is a possible candidate as a bioterror weapon. But it's also very common. Tularemia has b...t's suspicious. "Almost all of the bacterial bioterror pathogens are in the environment and in the air na...

Smooth sailing: 'cruise ship virus' tackled by UH, Baylor College of Medicine

...bed the "Cruise Ship Virus." This RCE is part of a national network of 10 other centers that support research focused on countering threats from bioterror agents and emerging infectious diseases. Each is comprised of a consortium of universities and complementary research institutions serving a specific...

New method for identifying microbes

...o identifying pathogens and distinguishing harmless bacteria from potential bioterror weapons. "Microbial communities are enormously diverse and complex, with ... In another test with possible applications for identifying agents used in bioterror attacks, the technique also clearly discriminated between closely related s...

How can we protect patients with weakened immune systems from influenza?

...ar deadlier because there is no pre-existing immunity in the population. Furthermore, although it has never been known to have been developed as a bioterror weapon, the influenza virus may be relatively easy to manipulate for such purposes in a laboratory ?which is why the federal government is funding med...

Mice studies illustrate potential of chimp/human antibodies to protect against smallpox

...g smallpox disease in 1980. However, concerns of a bioterror attack involving the highly contagious and fatal v... to develop effective measures against a potential bioterror attack involving the deadly smallpox virus," says ...vailable that everyone could use in the event of a bioterror attack," says NIAID Director Anthony S. Fauci, M.D...

Human trial proves ricin vaccine safe, induces neutralizing antibodies; further tests planned

... Scientists have completed the first human clinical trial of a recombinant vaccine for the deadly toxin ricin ?a potential bioterror threat ?and the results indicate the vaccine is safe and effective in eliciting ricin-neutralizing antibodies, the UT Southwestern Medical Center rese...

The bioweapon is in the post

...ncovered by a New Scientist investigation into the bioterror risks posed by the booming business of gene synthe...creened orders for DNA sequences that might pose a bioterror threat. Of the 12 companies that replied, just fiv...by the US government as "select agents" that raise bioterror concerns. But not all of these sequences are dange...

bioterror in Biological Technology

UCF professor develops vaccine to protect against black plague bioterror attack

A University of Central Florida researcher may have found a defense against the Black Plague, a disease that wiped out a third of Europe's population in the Middle Ages and which government agencies perceive as a terrorist threat today. UCF Professor Henry Daniell and his team have developed a...

UCF professor develops vaccine to protect against black plague bioterror attack

A University of Central Florida researcher may have found a defense against the Black Plague, a disease that wiped out a third of Europe's population in the Middle Ages and which government agencies perceive as a terrorist threat today. UCF Professor Henry Daniell and his team have developed a...

Medical College lands $8.1M grant to detect bird flu, bioterror agents

Milwaukee, Wis. - The Medical College of Wisconsin , in response to the federal government's call for accelerated research, has been awarded a five-year, $8.1 million federal grant to develop a rapid, automated diagnostic device to test for avian flu and the majority of potential bioterrorism ag...

Diamond Film May Enable Critical New Sensors For Bioterror

MADISON - In this time of the chronic threat of terrorism and the possibility of war with an adversary who may be armed with biological weapons, high on the wish list of security agencies and battlefield commanders is a quick and easy way to detect the presence of dangerous biological agents. No...

DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD

... based on its technology, including orBec(R) and LPM(TM), particularly in light of the significant uncertainty inherent in developing vaccines against bioterror threats, manufacturing and conducting preclinical and clinical trials of vaccines, and obtaining regulatory approvals, that its cash expenditures will...

Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza(TM) (Cethromycin) in Community Acquired Pneumonia

...gent to combat CAP as well as other lethal pathogens that represent serious bioterror threats to public health, and we intend to explore all avenues that can lea...DTRA), to fund NDA-enabling studies to evaluate Restanza's efficacy against bioterror agents such as tularemia, plague and melioidosis. In June, the company anno...

DOR BioPharma Announces Issuance of European Patent for its LPM(TM) Oral Drug Delivery Technology

...ased on its technology, including orBec(R) and LPM (TM) , particularly in light of the significant uncertainty inherent in developing vaccines against bioterror threats, manufacturing and conducting preclinical and clinical trials of vaccines, and obtaining regulatory approvals, that its cash expenditures will...

DOR BioPharma Announces Publication of orBec(R) Clinical Pulmonary Data in Bone Marrow Transplantation

...ize products based on its technology, including orBec(R), particularly in light of the significant uncertainty inherent in developing vaccines against bioterror threats, manufacturing and conducting preclinical and clinical trials of vaccines, and obtaining regulatory approvals, that its cash expenditures will...

Advanced Life Sciences' Restanza(TM) Shows 100% Survival In Confirmatory Anthrax Study

...keting in this or any other indication. In addition to its development in anthrax, Restanza is also being developed to combat other high priority bioterror agents such as Fransicella tularensis (tularemia) , Yersinia pestis (plague) and Burkholderia pseudomallei (melioidosis) under a two year, $3...

DOR BioPharma Reports 1st Quarter 2009 Financial Results and Reviews Recent Accomplishments

...ize products based on its technology, including orBec(R), particularly in light of the significant uncertainty inherent in developing vaccines against bioterror threats, manufacturing and conducting preclinical and clinical trials of vaccines, and obtaining regulatory approvals, that its cash expenditures will...